drugset / Trial / NCT04898023

Zinc and Green Tea Extract for Community Respiratory Viral Infections

NCT04898023

Phase 2 Terminated 17 enrolled University of Missouri-Columbia
RandomizedParallel-groupDouble-blindTreatment

Summary

Zinc and green tea supplementation have both been independently studied for supporting immune health during cold and flu-like illness in non-hospitalized patients with clinical trials demonstrating promising but inconsistent results. Combination therapy may offer an improved effect as the antioxidant compounds found in green tea have been shown to increase cellular zinc concentrations thereby inhibiting viral replication. This study seeks to evaluate the effect of combination supplementation using established doses of zinc and green tea extract on symptom duration and severity from cold and flu-like illness, including COVID-19, in adult community patients enrolled in a randomized placebo-controlled trial.

Timeline

Start
2022-09-21
Primary completion
2023-10-31
Completion
2023-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin C Other / unclassified Oral
Subject Zinc Sulfate Unknown Oral
Subject green tea extract Unknown Oral